Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.
暂无分享,去创建一个
[1] D. Glaze,et al. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched control study. , 2017, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[2] D. J. Driscoll,et al. Elevated plasma oxytocin levels in children with Prader–Willi syndrome compared with healthy unrelated siblings , 2016, American journal of medical genetics. Part A.
[3] M. Butler,et al. Original article Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study , 2016 .
[4] M. Coupaye,et al. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi Syndrome: a matched control study. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[5] O. Ilkayeva,et al. Metabolic profiling in Prader–Willi syndrome and nonsyndromic obesity: sex differences and the role of growth hormone , 2015, Clinical endocrinology.
[6] V. Gross‐Tsur,et al. Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade. , 2015, Human reproduction.
[7] D. Broadhurst,et al. Macronutrient Regulation of Ghrelin and Peptide YY in Pediatric Obesity and Prader-Willi Syndrome. , 2015, The Journal of clinical endocrinology and metabolism.
[8] K. Steinbeck,et al. Postprandial metabolism in adults with prader–willi syndrome , 2015, Obesity.
[9] C. Höybye. Growth hormone treatment of Prader–Willi syndrome has long‐term, positive effects on body composition , 2015, Acta paediatrica.
[10] K. Clément,et al. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity. , 2015, The Journal of clinical endocrinology and metabolism.
[11] A. Haqq,et al. Hormonal and metabolic responses to endurance exercise in children with Prader-Willi syndrome and non-syndromic obesity. , 2015, Metabolism: clinical and experimental.
[12] J. Rotteveel,et al. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment. , 2015, The Journal of clinical endocrinology and metabolism.
[13] S. Adami,et al. Adults with Prader–Willi Syndrome have Weaker Bones: Effect of Treatment with GH and Sex Steroids , 2015, Calcified Tissue International.
[14] Daniel J Driscoll,et al. Growth Charts for Non-Growth Hormone Treated Prader-Willi Syndrome , 2015, Pediatrics.
[15] A. Hokken-Koelega,et al. Behavior in children with Prader–Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study , 2015, European Child & Adolescent Psychiatry.
[16] J. Tucker,et al. Patterns of habitual physical activity in youth with and without Prader-Willi Syndrome. , 2014, Research in developmental disabilities.
[17] A. Guastella,et al. A double‐blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome , 2014, American journal of medical genetics. Part A.
[18] A. Holland,et al. Ageing in people with Prader–Willi syndrome: mortality in the UK population cohort and morbidity in an older sample of adults , 2014, Psychological Medicine.
[19] J. Hamilton,et al. Clinically Important Age-Related Differences in Sleep Related Disordered Breathing in Infants and Children with Prader-Willi Syndrome , 2014, PloS one.
[20] Z. Aycan,et al. Prader-Willi Syndrome and Growth Hormone Deficiency , 2014, Journal of clinical research in pediatric endocrinology.
[21] N. Dhanesha,et al. Inhibition of the methionine aminopeptidase 2 enzyme for the treatment of obesity , 2014, Diabetes, metabolic syndrome and obesity : targets and therapy.
[22] Jennifer L Miller,et al. An open‐label pilot study of N‐acetylcysteine for skin‐picking in Prader–Willi syndrome , 2014, American journal of medical genetics. Part A.
[23] F. Benarroch,et al. Management of hypogonadism in adolescent girls and adult women with Prader–Willi syndrome , 2013, American journal of medical genetics. Part A.
[24] J. Rotteveel,et al. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. , 2013, The Journal of clinical endocrinology and metabolism.
[25] K. Clément,et al. Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity , 2013, International Journal of Obesity.
[26] J. Emerick,et al. Endocrine manifestations and management of Prader-Willi syndrome , 2013, International Journal of Pediatric Endocrinology.
[27] H. Herzog,et al. Mouse models of Prader–Willi Syndrome: A systematic review , 2013, Frontiers in Neuroendocrinology.
[28] John J. Kopchick,et al. Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome , 2013, The Journal of clinical endocrinology and metabolism.
[29] S. Ito,et al. The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome. , 2012, Endocrine journal.
[30] D. Barbara,et al. Intraoperative Adrenal Insufficiency in a Patient with Prader-Willi Syndrome , 2012, Journal of clinical medicine research.
[31] S. Wong,et al. Ghrelin Level and Weight Loss After Laparoscopic Sleeve Gastrectomy and Gastric Mini-Bypass for Prader–Willi Syndrome in Chinese , 2012, Obesity Surgery.
[32] A. Markou,et al. N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking , 2012, Psychopharmacology.
[33] J. Laven,et al. Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study. , 2012, The Journal of clinical endocrinology and metabolism.
[34] A. Salvatoni,et al. Assessment of central adrenal insufficiency in children and adolescents with Prader–Willi syndrome , 2012, Clinical endocrinology.
[35] M. Sinnema,et al. Aging in Prader–Willi syndrome: Twelve persons over the age of 50 years , 2012, American journal of medical genetics. Part A.
[36] J. Rotteveel,et al. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study. , 2012, The Journal of clinical endocrinology and metabolism.
[37] J. Whittington,et al. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome , 2012, International Journal of Obesity.
[38] D. J. Driscoll,et al. Prader-Willi syndrome. , 1984, Current problems in pediatrics.
[39] J. Frystyk,et al. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. , 2012, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[40] F. de Jong,et al. Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader–Willi syndrome , 2011, Clinical endocrinology.
[41] M. Tauber,et al. Efficacy of modafinil on excessive daytime sleepiness in Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.
[42] C. Mantoulan,et al. Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients , 2011, Orphanet journal of rare diseases.
[43] K. Hoffman. Animal models of obsessive compulsive disorder: recent findings and future directions , 2011, Expert opinion on drug discovery.
[44] K. Steinbeck,et al. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. , 2011, The Journal of clinical endocrinology and metabolism.
[45] D. C. Driscoll,et al. Nutritional phases in Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.
[46] N. Katsilambros,et al. Meal-induced thermogenesis and macronutrient oxidation in lean and obese women after consumption of carbohydrate-rich and fat-rich meals. , 2011, Nutrition.
[47] D. J. Driscoll,et al. Carnitine and coenzyme Q10 levels in individuals with Prader–Willi syndrome , 2011, American journal of medical genetics. Part A.
[48] S. Grambow,et al. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. , 2010, The Journal of clinical endocrinology and metabolism.
[49] M. Tauber,et al. Endocrine Disorders in Children with Prader-Willi Syndrome – Data from 142 Children of the French Database , 2010, Hormone Research in Paediatrics.
[50] K. Cianflone,et al. Cardiovascular and metabolic risk profile and acylation-stimulating protein levels in children with Prader-Willi syndrome and effects of growth hormone treatment. , 2010, The Journal of clinical endocrinology and metabolism.
[51] Health Supervision for Children With Prader-Willi Syndrome , 2016, Pediatric Clinical Practice Guidelines & Policies.
[52] H. Duivenvoorden,et al. Randomized controlled trial to investigate the effects of growth hormone treatment on scoliosis in children with Prader-Willi syndrome. , 2009, The Journal of clinical endocrinology and metabolism.
[53] R. Wevrick,et al. Necdin, a Prader-Willi syndrome candidate gene, regulates gonadotropin-releasing hormone neurons during development. , 2008, Human molecular genetics.
[54] P. Navas,et al. Coenzyme Q10 deficiencies in neuromuscular diseases. , 2009, Advances in experimental medicine and biology.
[55] S. Grambow,et al. Ghrelin concentrations in Prader–Willi syndrome (PWS) infants and children: changes during development , 2008, Clinical endocrinology.
[56] M. Tauber,et al. Recommendations for the diagnosis and management of Prader-Willi syndrome. , 2008, The Journal of clinical endocrinology and metabolism.
[57] H. Duivenvoorden,et al. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader–Willi syndrome , 2008, Clinical endocrinology.
[58] V. Rousson,et al. Developmental profiles in young children with Prader–Labhart–Willi syndrome: Effects of weight and therapy with growth hormone or coenzyme Q10 , 2008, American journal of medical genetics. Part A.
[59] U. Francke,et al. SnoRNA Snord116 (Pwcr1/MBII-85) Deletion Causes Growth Deficiency and Hyperphagia in Mice , 2008, PloS one.
[60] C. Cuffari,et al. Critical Analysis of Bariatric Procedures in Prader-Willi Syndrome , 2008, Journal of pediatric gastroenterology and nutrition.
[61] S. Grambow,et al. Altered distribution of adiponectin isoforms in children with Prader–Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones , 2007, Clinical endocrinology.
[62] C. Stewart,et al. Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. , 2007, Human molecular genetics.
[63] L. Reddy,et al. Behavioral and Emotional Symptoms of Children and Adolescents with Prader-Willi Syndrome , 2007, Journal of autism and developmental disorders.
[64] M. Butler. Management of obesity in Prader–Willi syndrome , 2006, Nature Clinical Practice Endocrinology &Metabolism.
[65] D. Cummings,et al. Ghrelin levels in young children with Prader-Willi syndrome. , 2006, The Journal of pediatrics.
[66] D. Swaab,et al. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome. , 2005, The Journal of clinical endocrinology and metabolism.
[67] N. Niikawa,et al. Cause of sudden, unexpected death of Prader–Willi syndrome patients with or without growth hormone treatment , 2005, American journal of medical genetics. Part A.
[68] M. Sacco,et al. Sudden Death in Prader-Willi Syndrome during Growth Hormone Therapy , 2005, Hormone Research in Paediatrics.
[69] E. Mignot,et al. Hypocretin deficiency in Prader–Willi syndrome , 2005, European journal of neurology.
[70] Z. Talebizadeh,et al. Insulin resistance and obesity‐related factors in Prader–Willi syndrome: Comparison with obese subjects , 2004, Clinical genetics.
[71] K. Devriendt,et al. Minimum prevalence, birth incidence and cause of death for Prader–Willi syndrome in Flanders , 2004, European Journal of Human Genetics.
[72] J. Fryns,et al. Prader–Willi syndrome: Causes of death in an international series of 27 cases , 2004, American journal of medical genetics. Part A.
[73] E. Zackai,et al. Unexpected death and critical illness in Prader–Willi syndrome: Report of ten individuals , 2004, American journal of medical genetics. Part A.
[74] A. Bondy,et al. Behavioral treatment of obesity in patients with Prader-Willi syndrome , 1978, Journal of Behavioral Medicine.
[75] C. Deal,et al. Sudden death in growth hormone-treated children with Prader-Willi syndrome. , 2004, The Journal of pediatrics.
[76] T. Shriver,et al. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. , 2003, The Journal of pediatrics.
[77] S. Dimauro,et al. Coenzyme Q10 levels in Prader‐Willi syndrome: Comparison with obese and non‐obese subjects , 2003, American journal of medical genetics. Part A.
[78] A. Haqq,et al. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. , 2003, The Journal of clinical endocrinology and metabolism.
[79] E. Dykens,et al. Psychiatric Disorders in Prader-Willi Syndrome , 2003, CNS drugs.
[80] Y. Nordmann,et al. Sudden Death of an Infant with Prader-Willi Syndrome – Not a Unique Case? , 2002, Neonatology.
[81] Y. Nordmann,et al. Fatal Outcome of Sleep Apnoea in PWS during the Initial Phase of Growth Hormone Treatment , 2002, Hormone Research in Paediatrics.
[82] M. Schwartz,et al. Elevated plasma ghrelin levels in Prader–Willi syndrome , 2002, Nature Medicine.
[83] A. Holland,et al. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. , 2002, Developmental medicine and child neurology.
[84] D. Allen,et al. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. , 2002, The Journal of clinical endocrinology and metabolism.
[85] Jimmy D Bell,et al. Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome. , 2002, The American journal of clinical nutrition.
[86] D. Allen,et al. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study. , 2002, Pediatrics.
[87] K. Õunap,et al. Sudden death of a girl with Prader-Willi syndrome. , 2002, Genetic counseling.
[88] P. Burman,et al. Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH. , 2001, Endocrine reviews.
[89] S. Schwartz,et al. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. , 2001, Pediatrics.
[90] D. Allen,et al. Sustained Benefits of Growth Hormone on Body Composition, Fat Utilization, Physical Strength and Agility, and Growth in Prader-Willi Syndrome are Dose-Dependent , 2001, Journal of pediatric endocrinology & metabolism : JPEM.
[91] G. Grugni,et al. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome , 2001, Journal of endocrinological investigation.
[92] R. Biancheri,et al. Hypersomnia in the Prader Willi syndrome: clinical-electrophysiological features and underlying factors , 2001, Clinical Neurophysiology.
[93] K. Brøndum‐Nielsen,et al. Fertility in Prader‐Willi syndrome: a case report with Angelman syndrome in the offspring , 2001, Acta paediatrica.
[94] Y. Schutz,et al. Meal-induced thermogenesis and obesity: is a fat meal a risk factor for fat gain in children? , 2001, The Journal of clinical endocrinology and metabolism.
[95] U. Eiholzer,et al. Growth Hormone Normalises Height, Prediction of Final Height and Hand Length in Children with Prader-Willi Syndrome after 4 Years of Therapy , 2000, Hormone Research in Paediatrics.
[96] D. Allen,et al. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. , 2000, The Journal of pediatrics.
[97] C. Williams,et al. Prader-Willi and Angelman syndromes: sister imprinted disorders. , 2000, American journal of medical genetics.
[98] K. Westerterp,et al. Energy expenditure at rest and during sleep in children with Prader-Willi syndrome is explained by body composition. , 2000, The American journal of clinical nutrition.
[99] A. Salvatoni,et al. GH/IGF-I axis in Prader-Willi syndrome: Evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli , 2000, Journal of endocrinological investigation.
[100] E. Ritzén,et al. Five years of growth hormone treatment in children with Prader‐Willi syndrome , 1999, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[101] C. Gillberg,et al. ‘A woman with Prader‐Willi syndrome gives birth to a healthy baby girl’ , 1999, Developmental medicine and child neurology.
[102] M. Sun,et al. Development and validation of a measurement system for assessment of energy expenditure and physical activity in Prader-Willi syndrome. , 1999, Obesity research.
[103] L. Molinari,et al. Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. , 1999, The Journal of pediatrics.
[104] D. Allen,et al. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study. , 1999, The Journal of pediatrics.
[105] J. Milerad,et al. Growth hormone treatment increases CO(2) response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. , 1999, European journal of pediatrics.
[106] L. Molinari,et al. Low insulin, IGF-I and IGFBP-3 levels in children with Prader-Labhart-Willi syndrome , 1998, European Journal of Pediatrics.
[107] M. B. Ranke,et al. Reference values for height and weight in Prader-Willi syndrome based on 315 patients , 1998, European Journal of Pediatrics.
[108] S. Buoni,et al. Growth hormone secretion in Prader-Willi syndrome , 1998, Journal of endocrinological investigation.
[109] Morabito,et al. Reduced growth hormone (GH) responsiveness to combined GH‐releasing hormone and pyridostigmine administration in the Prader–Willi syndrome , 1998, Clinical endocrinology.
[110] N. B. Johnson,et al. Growth Failure in Prader-Willi Syndrome Is Secondary to Growth Hormone Deficiency , 1998, Hormone Research in Paediatrics.
[111] T. Brismar,et al. Growth hormone treatment of children with Prader‐Willi syndrome affects linear growth and body composition favourably , 1998, Acta paediatrica.
[112] J. Fryns,et al. Sudden death in children with Prader-Willy syndrome: a call for collaboration. , 1998, Genetic counseling.
[113] P. Brambilla,et al. Peculiar body composition in patients with Prader-Labhart-Willi syndrome. , 1997, The American journal of clinical nutrition.
[114] D. Schuster,et al. Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. , 1996, Metabolism: clinical and experimental.
[115] M. Sarrantonio,et al. Growth Hormone Secretion and Effects of Growth Hormone Therapy on Growth Velocity and Weight Gain in Children with Prader-Willi Syndrome , 1996, Journal of pediatric endocrinology & metabolism : JPEM.
[116] D. Gozal,et al. Hypoxic and hypercapnic ventilatory responses in Prader-Willi syndrome. , 1994, Journal of applied physiology.
[117] E. Hollander,et al. A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. , 1994, The Journal of neuropsychiatry and clinical neurosciences.
[118] P. Davies,et al. Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome. , 1993, American journal of mental retardation : AJMR.
[119] K. Silverthorn,et al. Beneficial effects of exercise on aerobic capacity and body composition in adults with Prader-Willi syndrome. , 1993, American journal of mental retardation : AJMR.
[120] M. Butler,et al. Prader-Willi syndrome: consensus diagnostic criteria. , 1993, Pediatrics.
[121] E. Ghigo,et al. Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome. , 1993, Hormone research.
[122] P. Pipes,et al. A nutrition survey of and recommendations for individuals with Prader-Willi syndrome who live in group homes. , 1992, Journal of the American Dietetic Association.
[123] W. Walker,et al. Parenteral protein-sparing modified fast in an obese adolescent with Prader-Willi syndrome. , 2009, Nutrition reviews.
[124] M. Butler,et al. Standards for selected anthropometric measurements in Prader-Willi syndrome. , 1991, Pediatrics.
[125] H. Berthoud,et al. Morphology and distribution of efferent vagal innervation of rat pancreas as revealed with anterograde transport of Dil , 1991, Brain Research.
[126] V. A. Holm,et al. Growth Hormone Secretion in Prader‐Willi Syndrome , 1990, Acta paediatrica Scandinavica.
[127] K. Segal,et al. Thermic effect of a meal over 3 and 6 hours in lean and obese men. , 1990, Metabolism: clinical and experimental.
[128] E. Ravussin,et al. Energy expenditure in humans: effects of dietary fat and carbohydrate. , 1990, The American journal of physiology.
[129] M. Polansky,et al. Thermic effect of food in lean and obese men. , 1988, The Journal of clinical investigation.
[130] L. Greenswag,et al. ADULTS WITH PRADER‐WILLI SYNDROME: A SURVEY OF 232 CASES , 1987 .
[131] R. Noack,et al. Diet-induced thermogenesis in man: thermic effects of single protein and carbohydrate test meals in lean and obese subjects. , 1987, Annals of nutrition & metabolism.
[132] E. Jéquier,et al. New evidence for a thermogenic defect in human obesity. , 1985, International journal of obesity.
[133] C. Lutton,et al. Cholesterol metabolism in lean and obese Zucker rats: effects of portacaval anastomosis. , 1985, International journal of obesity.
[134] Y. Schutz,et al. Diet-induced thermogenesis measured over a whole day in obese and nonobese women. , 1984, The American journal of clinical nutrition.
[135] D. Schoeller,et al. ENERGY EXPENDITURE AND BODY COMPOSITION IN PRADER-WILLI SYNDROME , 1984, Pediatric Research.
[136] R. Taylor,et al. A clinical note on food preference of individuals with Prader-Willi syndrome: the need for empirical research. , 2008, Journal of mental deficiency research.
[137] S. Sulzbacher,et al. Activity levels of persons with Prader-Willi syndrome. , 1983, American journal of mental deficiency.
[138] G. Bray,et al. The Prader‐Willi Syndrome: A Study of 40 Patients and a Review of the Literature , 1983, Medicine.
[139] J. Kriz,et al. Management of a patient with Prader-Willi syndrome by a dental-dietary team. , 1981, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.
[140] Heiman Mf. The management of obesity in the post-adolescent developmentally disabled client with Prader-Willi syndrome. , 1978 .
[141] M. Heiman. The management of obesity in the post-adolescent developmentally disabled client with Prader-Willi syndrome. , 1978, Adolescence.
[142] V. A. Holm,et al. Management of Prader-Willi Syndrome , 1977, The Journal of pediatrics.
[143] G. Blackburn,et al. Metabolic aspects of a protein-sparing modified fast in the dietary management of Prader-Willi obesity. , 1977, The New England journal of medicine.
[144] V. A. Holm,et al. Food and children with Prader-Willi syndrome. , 1976, American journal of diseases of children.
[145] A. Gormican,et al. Out-patient dietary management in the Prader-Willi syndrome. , 1976, Journal of the American Dietetic Association.
[146] R. Ruvalcaba,et al. Some aspects of carbohydrate metabolism in Prader-Willi syndrome. , 2008, Journal of mental deficiency research.
[147] Pipes Pl,et al. Weight control of children with Prader-Willi syndrome. , 1973 .
[148] V. A. Holm,et al. Weight control of children with Prader-Willi syndrome. , 1973, Journal of the American Dietetic Association.
[149] J. Jancar. Prader-Willi syndrome. (Hypotonia, obesity, hypogonadism, growth and mental retardation). , 2010, Journal of mental deficiency research.
[150] Evans Pr. HYPOGENITAL DYSTROPHY WITH DIABETIC TENDENCY. , 1964 .